Study explains how India keeps diabetes medicines affordable
A study by diabetologists examined how India keeps otherwise-expensive diabetes medicines affordable. It links India's low medication prices to its role as a major pharmaceutical exporter, supported by legislation that prevents 'patent evergreening' and enables large-scale generic drug manufacturing, keeping essential medicines within reach of patients.
Nabka Insight
India's generic-drugs and anti-evergreening framework is a recurring health-policy theme.
Powered by AIKey facts
- Study conducted by diabetologists.
- Affordability tied to India's role as a major pharmaceutical exporter.
- Anti-'patent evergreening' law enables generic manufacturing.
Relevant forRailways · SSC · State PSC · UPSC